Anew Medical, Inc.

NASDAQ (USD): Anew Medical, Inc. (WENA)

Last Price

0.726

Today's Change

-0.029 (3.84%)

Day's Change

0.725 - 0.78

Trading Volume

20,626

Profile
WENA

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Joseph Sinkule Pharm.D. Dr. Joseph Sinkule Pharm.D.

Full Time Employees:  1 1

IPO Date: 

CIK: 

ISIN:  US03465T1088 US03465T1088

CUSIP: 

Beta:  0.02 0.02

Last Dividend:  0.00 0.00

Dcf Diff:  0.87 0.87

Dcf:  -0.15 -0.15

Description

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

Address

13576 Walnut Street,
Omaha, NE 68144, US

833 931 6330

http://www.anewmeds.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment